SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-043611
Filing Date
2023-04-10
Accepted
2023-04-10 16:30:54
Documents
1
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2311744-2_4aseq1.html 4/A  
1 OWNERSHIP DOCUMENT tm2311744-2_4aseq1.xml 4/A 4019
  Complete submission text file 0001104659-23-043611.txt   5400
Mailing Address C/O ALEXZA PHARMACEUTICALS, INC. 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Lippe Robert A (Reporting) CIK: 0001600757 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39724 | Film No.: 23811467

Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Issuer) CIK: 0001819576 (see all company filings)

IRS No.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations